Trials / Completed
CompletedNCT01444729
Post Approval Commitment Study
A Non-Interventional Post Approval Commitment Study To Evaluate The Outcomes Of The Various Treatment Options For Dupuytren's Contracture
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 305 (actual)
- Sponsor
- Endo Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
An agreement has been made to conduct a post-approval commitment study that provides supplementary information relating to the use of Xiapex® as well as other non-pharmacological treatments for Dupuytren's contracture by health care professionals in a real world clinical setting.
Detailed description
phase 4, open label, multi-center, prospective non-interventional descriptive
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Xiapex | Xiapex administration will follow SMPC |
| PROCEDURE | surgery | Non-pharmacological treatment |
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2015-11-01
- Completion
- 2015-11-01
- First posted
- 2011-10-03
- Last updated
- 2017-10-26
Locations
7 sites across 2 countries: Norway, Spain
Source: ClinicalTrials.gov record NCT01444729. Inclusion in this directory is not an endorsement.